Role of biomedical measurements on severity and outcomes of patients with COVID-19 infection: A retrospective follow-up study

Authors

DOI:

https://doi.org/10.3126/ajms.v13i7.43640

Keywords:

COVID-19, Inflammation, Mortality, Thrombosis

Abstract

Background: The clinical manifestations and laboratory biomarkers in the 1st week of the disease course may impact the patient’s final clinical outcome.

Aims and Objectives: In this study, we aimed whether biomedical measurements at the early stage can predict the severity and outcomes of patients with COVID-19. The patients aged 18 years and older who were diagnosed with COVID-19 by the internist met the initial eligibility criterion. The patients with medical records of the laboratory indicators and clinical outcomes were included in this study.

Materials and Methods: In this retrospective follow-up study, 155 clinically ill patients with COVID-19 were followed up until recovery and death from the disease.

Results: The average age of the COVID-19 patients was 49.7 (Sta. deviation: 16.6) aged between 18 and 90 years. The patients had mild severity of disease (67.10%) followed by moderate (19.36%), severe (7.74%), and critical (5.81%). The study found that 6.45% (n=10) of the patients died and 93.55% (n=145) were recovered from the disease. The concentrations of C-reactive protein (CRP), D-dimer, ferritin, lactate dehydrogenase (LDH), lymphocytes, and white blood cell were increased with increasing severities and in dead patients. D-dimer and CRP were the main contributing factors to the higher severity of disease and mortality among COVID-19 patients. The contributed symptoms to disease severity were diarrhea, epigastric pain, shortness of breath, headache, and fever. The higher LDH and being male were contributed to higher disease severity.

Conclusion: This study showed that CRP and D-dimer are the main factors contributing to the severity and mortality among COVID-19 patients.

Downloads

Download data is not yet available.
Abstract
186
PDF
180

Downloads

Published

2022-07-01

How to Cite

Deldar Morad Abdulah, & Hemin Khalid Saber. (2022). Role of biomedical measurements on severity and outcomes of patients with COVID-19 infection: A retrospective follow-up study. Asian Journal of Medical Sciences, 13(7), 14–20. https://doi.org/10.3126/ajms.v13i7.43640

Issue

Vol. 13 No. 7 (2022)

Section

Original Articles

License

Copyright (c) 2022 Asian Journal of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).